Evidence map›Paper›PMID 38968206›Full record

ArticlePloS one2024

Using multi-label ensemble CNN classifiers to mitigate labelling inconsistencies in patch-level Gleason grading.

Muhammad Asim Butt, Muhammad Farhat Kaleem, Muhammad Bilal, Muhammad Shehzad Hanif

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. In Silico Analysis of Squamous Cell Carcinoma.Advances in experimental medicine and biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Muhammad Asim ButtDepartment of Electrical Engineering, University of Management and Technology, Lahore, Pakistan.
Muhammad Farhat KaleemSchool of Engineering, University of Management and Technology, Lahore, Pakistan.
Muhammad BilalCenter of Excellence in Intelligent Engineering Systems, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID 0000-0002-6446-8687
Muhammad Shehzad HanifCenter of Excellence in Intelligent Engineering Systems, King Abdulaziz University, Jeddah, Saudi Arabia.

Funding

Institutional Fund Projects IFPIP: 1825-135-1443Ministry of Education and Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, Saudi Arabia
6 · The paper itself

Abstract

This paper presents a novel approach to enhance the accuracy of patch-level Gleason grading in prostate histopathology images, a critical task in the diagnosis and prognosis of prostate cancer. This study shows that the Gleason grading accuracy can be improved by addressing the prevalent issue of label inconsistencies in the SICAPv2 prostate dataset, which employs a majority voting scheme for patch-level labels. We propose a multi-label ensemble deep-learning classifier that effectively mitigates these inconsistencies and yields more accurate results than the state-of-the-art works. Specifically, our approach leverages the strengths of three different one-vs-all deep learning models in an ensemble to learn diverse features from the histopathology images to individually indicate the presence of one or more Gleason grades (G3, G4, and G5) in each patch. These deep learning models have been trained using transfer learning to fine-tune a variant of the ResNet18 CNN classifier chosen after an extensive ablation study. Experimental results demonstrate that our multi-label ensemble classifier significantly outperforms traditional single-label classifiers reported in the literature by at least 14% and 4% on accuracy and f1-score metrics respectively. These results underscore the potential of our proposed machine learning approach to improve the accuracy and consistency of prostate cancer grading.

Indexed as

Deep LearningNeoplasm GradingProstatic NeoplasmsAlgorithmsHumansMaleNeural Networks, ComputerProstate

Identifiers

PMID38968206
PMCPMC11226137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.